Notation |
|
xv | |
|
|
1 | (13) |
|
|
1 | (2) |
|
Tests, classification and the broader context |
|
|
1 | (1) |
|
Disease screening versus diagnosis |
|
|
2 | (1) |
|
Criteria for a useful medical test |
|
|
2 | (1) |
|
|
3 | (5) |
|
Scale for the test result |
|
|
4 | (1) |
|
Selection of study subjects |
|
|
4 | (1) |
|
|
5 | (1) |
|
|
5 | (1) |
|
|
6 | (2) |
|
|
8 | (3) |
|
|
8 | (1) |
|
|
8 | (2) |
|
Pancreatic cancer serum biomarkers study |
|
|
10 | (1) |
|
Hepatitis metastasis ultrasound study |
|
|
10 | (1) |
|
CARET PSA biomarker study |
|
|
10 | (1) |
|
Ovarian cancer gene expression study |
|
|
11 | (1) |
|
|
11 | (1) |
|
St Louis prostate cancer screening study |
|
|
11 | (1) |
|
|
11 | (1) |
|
|
12 | (2) |
|
Measures of accuracy for binary tests |
|
|
14 | (21) |
|
|
14 | (7) |
|
|
14 | (1) |
|
Disease-specific classification probabilities |
|
|
14 | (2) |
|
|
16 | (1) |
|
Diagnostic likelihood ratios |
|
|
17 | (4) |
|
Estimating accuracy with data |
|
|
21 | (6) |
|
|
21 | (1) |
|
Proportions: (FPF, TPF) and (PPV, NPV) |
|
|
22 | (2) |
|
Ratios of proportions: DLRs |
|
|
24 | (1) |
|
Estimation from a case-control study |
|
|
25 | (1) |
|
Merits of case-control versus cohort studies |
|
|
26 | (1) |
|
Quantifying the relative accuracy of tests |
|
|
27 | (6) |
|
Comparing classification probabilities |
|
|
28 | (1) |
|
Comparing predictive values |
|
|
29 | (1) |
|
Comparing diagnostic likelihood ratios |
|
|
30 | (1) |
|
|
31 | (2) |
|
|
33 | (1) |
|
|
34 | (1) |
|
Comparing binary tests and regression analysis |
|
|
35 | (31) |
|
Study designs for comparing tests |
|
|
35 | (2) |
|
|
35 | (1) |
|
|
36 | (1) |
|
Comparing accuracy with unpaired data |
|
|
37 | (4) |
|
Empirical estimators of comparative measures |
|
|
37 | (1) |
|
|
38 | (3) |
|
Comparing accuracy with paired data |
|
|
41 | (7) |
|
|
41 | (1) |
|
Estimation of comparative measures |
|
|
41 | (1) |
|
Wide or long data representations |
|
|
42 | (1) |
|
|
43 | (1) |
|
Efficiency of paired versus unpaired designs |
|
|
44 | (1) |
|
|
45 | (1) |
|
|
45 | (3) |
|
The regression modeling framework |
|
|
48 | (3) |
|
Factors potentially affecting test performance |
|
|
48 | (2) |
|
Questions addressed by regression modeling |
|
|
50 | (1) |
|
Notation and general set-up |
|
|
50 | (1) |
|
Regression for true and false positive fractions |
|
|
51 | (7) |
|
Binary marginal GLM models |
|
|
51 | (1) |
|
Fitting marginal models to data |
|
|
51 | (2) |
|
Illustration: factors affecting test accuracy |
|
|
53 | (2) |
|
Comparing tests with regression analysis |
|
|
55 | (3) |
|
Regression modeling of predictive values |
|
|
58 | (3) |
|
Model formulation and fitting |
|
|
58 | (1) |
|
|
59 | (1) |
|
The incremental value of a test for prediction |
|
|
59 | (2) |
|
Regression models for DLRs |
|
|
61 | (2) |
|
|
61 | (1) |
|
|
61 | (1) |
|
Comparing DLRs of two tests |
|
|
61 | (1) |
|
Relationships with other regression models |
|
|
62 | (1) |
|
|
63 | (1) |
|
|
64 | (2) |
|
The receiver operating characteristic curve |
|
|
66 | (30) |
|
|
66 | (1) |
|
Examples of non-binary tests |
|
|
66 | (1) |
|
Dichotomizing the test result |
|
|
66 | (1) |
|
The ROC curve for continuous tests |
|
|
67 | (9) |
|
|
67 | (1) |
|
Mathematical properties of the ROC curve |
|
|
68 | (3) |
|
Attributes of and uses for the ROC curve |
|
|
71 | (4) |
|
Restrictions and alternatives to the ROC curve |
|
|
75 | (1) |
|
|
76 | (5) |
|
The area under the ROC curve (AUC) |
|
|
77 | (2) |
|
The ROC(t0) and partial AUC |
|
|
79 | (1) |
|
|
80 | (1) |
|
Measures of distance between distributions |
|
|
81 | (1) |
|
|
81 | (4) |
|
|
82 | (1) |
|
|
83 | (1) |
|
|
84 | (1) |
|
The ROC for ordinal tests |
|
|
85 | (7) |
|
Tests with ordered discrete results |
|
|
85 | (1) |
|
The latent decision variable model |
|
|
86 | (1) |
|
Identification of the latent variable ROC |
|
|
86 | (2) |
|
Changes in accuracy versus thresholds |
|
|
88 | (1) |
|
|
89 | (3) |
|
Summary measures for the discrete ROC curve |
|
|
92 | (1) |
|
|
92 | (2) |
|
|
94 | (2) |
|
|
96 | (34) |
|
|
96 | (1) |
|
|
96 | (1) |
|
|
96 | (1) |
|
|
97 | (14) |
|
|
97 | (2) |
|
Sampling variability at a threshold |
|
|
99 | (1) |
|
Sampling variability of ROCe(t) |
|
|
99 | (4) |
|
The empirical AUC and other indices |
|
|
103 | (1) |
|
Variability in the empirical AUC |
|
|
104 | (3) |
|
Comparing empirical ROC curves |
|
|
107 | (2) |
|
Illustration: pancreatic cancer biomarkers |
|
|
109 | (1) |
|
Discrete ordinal data ROC curves |
|
|
110 | (1) |
|
Modeling the test result distributions |
|
|
111 | (3) |
|
Fully parametric modeling |
|
|
111 | (1) |
|
Semiparametric location-scale models |
|
|
112 | (2) |
|
Arguments against modeling test results |
|
|
114 | (1) |
|
Parametric distribution-free methods: ordinal tests |
|
|
114 | (5) |
|
The binormal latent variable framework |
|
|
115 | (2) |
|
Fitting the discrete binormal ROC function |
|
|
117 | (1) |
|
Generalizations and comparisons |
|
|
118 | (1) |
|
Parametric distribution-free methods: continuous tests |
|
|
119 | (6) |
|
|
119 | (1) |
|
|
120 | (4) |
|
Inference with parametric distribution-free methods |
|
|
124 | (1) |
|
|
125 | (2) |
|
|
127 | (1) |
|
Proofs of theoretical results |
|
|
128 | (2) |
|
Covariate effects on continuous and ordinal tests |
|
|
130 | (38) |
|
|
130 | (6) |
|
|
130 | (1) |
|
|
131 | (1) |
|
Omitting covariates/pooling data |
|
|
132 | (4) |
|
|
136 | (8) |
|
Non-diseased as the reference population |
|
|
136 | (1) |
|
The homogenous population |
|
|
137 | (2) |
|
Nonparametric regression quantiles |
|
|
139 | (1) |
|
Parametric estimation of SD,Z |
|
|
140 | (1) |
|
|
141 | (1) |
|
|
141 | (2) |
|
|
143 | (1) |
|
Modeling covariate effects on test results |
|
|
144 | (7) |
|
|
144 | (1) |
|
Induced ROC curves for continuous tests |
|
|
144 | (4) |
|
Semiparametric location-scale families |
|
|
148 | (2) |
|
Induced ROC curves for ordinal tests |
|
|
150 | (1) |
|
Random effect models for test results |
|
|
150 | (1) |
|
Modeling covariate effects on ROC curves |
|
|
151 | (13) |
|
The ROC--GLM regression model |
|
|
152 | (2) |
|
Fitting the model to data |
|
|
154 | (3) |
|
|
157 | (2) |
|
|
159 | (5) |
|
Approaches to ROC regression |
|
|
164 | (2) |
|
Modeling ROC summary indices |
|
|
164 | (1) |
|
|
164 | (2) |
|
|
166 | (1) |
|
|
167 | (1) |
|
Incomplete data and imperfect reference tests |
|
|
168 | (46) |
|
Verification biased sampling |
|
|
168 | (12) |
|
|
168 | (2) |
|
The missing at random assumption |
|
|
170 | (1) |
|
Correcting for bias with Bayes' theorem |
|
|
170 | (1) |
|
Inverse probability weighting/imputation |
|
|
171 | (1) |
|
Sampling variability of corrected estimates |
|
|
172 | (3) |
|
Adjustments for other biasing factors |
|
|
175 | (2) |
|
|
177 | (2) |
|
|
179 | (1) |
|
Verification restricted to screen positives |
|
|
180 | (14) |
|
Extreme verification bias |
|
|
180 | (1) |
|
Identifiable parameters for a single test |
|
|
181 | (2) |
|
|
183 | (2) |
|
Evaluating covariate effects on (DP, FP) |
|
|
185 | (2) |
|
Evaluating covariate effects on (TPF, FPF) and on prevalence |
|
|
187 | (2) |
|
Evaluating covariate effects on (rTPF, rFPF) |
|
|
189 | (4) |
|
|
193 | (1) |
|
Imperfect reference tests |
|
|
194 | (13) |
|
|
194 | (1) |
|
Effects on accuracy parameters |
|
|
194 | (3) |
|
Classic latent class analysis |
|
|
197 | (3) |
|
Relaxing the conditional independence assumption |
|
|
200 | (3) |
|
A critique of latent class analysis |
|
|
203 | (2) |
|
|
205 | (1) |
|
Composite reference standards |
|
|
206 | (1) |
|
|
207 | (2) |
|
|
209 | (1) |
|
Proofs of theoretical results |
|
|
210 | (4) |
|
Study design and Hypothesis testing |
|
|
214 | (39) |
|
The phases of medical test development |
|
|
214 | (4) |
|
|
214 | (1) |
|
Five phases for the development of a medical test |
|
|
215 | (3) |
|
Sample sizes for phase 2 studies |
|
|
218 | (11) |
|
Retrospective validation of a binary test |
|
|
218 | (2) |
|
Retrospective validation of a continuous test |
|
|
220 | (4) |
|
Sample size based on the AUC |
|
|
224 | (4) |
|
|
228 | (1) |
|
Sample sizes for phase 3 studies |
|
|
229 | (10) |
|
Comparing two binary tests---paired data |
|
|
229 | (4) |
|
Comparing two binary tests---unpaired data |
|
|
233 | (1) |
|
Evaluating population effects on test performance |
|
|
233 | (1) |
|
Comparisons with continuous test results |
|
|
234 | (3) |
|
Estimating the threshold for screen positivity |
|
|
237 | (1) |
|
Remarks on phase 3 analyses |
|
|
238 | (1) |
|
Sample sizes for phase 4 studies |
|
|
239 | (6) |
|
Designs for inference about (FPF, TPF) |
|
|
239 | (2) |
|
Designs for predictive values |
|
|
241 | (2) |
|
|
243 | (1) |
|
Selected verification of screen negatives |
|
|
244 | (1) |
|
|
245 | (1) |
|
Matching and stratification |
|
|
246 | (2) |
|
|
246 | (1) |
|
|
247 | (1) |
|
|
248 | (3) |
|
|
251 | (2) |
|
More topics and conclusions |
|
|
253 | (27) |
|
|
253 | (6) |
|
|
253 | (1) |
|
Design of a meta-analysis study |
|
|
253 | (2) |
|
|
255 | (3) |
|
Binomial regression models |
|
|
258 | (1) |
|
Incorporating the time dimension |
|
|
259 | (8) |
|
|
259 | (1) |
|
Incident cases and long-term control |
|
|
260 | (3) |
|
Interval cases and controls |
|
|
263 | (3) |
|
|
266 | (1) |
|
Longitudinal measurements |
|
|
266 | (1) |
|
Combining multiple test results |
|
|
267 | (10) |
|
|
267 | (2) |
|
The likelihood ratio principle |
|
|
269 | (2) |
|
Optimality of the risk score |
|
|
271 | (3) |
|
Estimating the risk score |
|
|
274 | (2) |
|
Development and assessment of the combination score |
|
|
276 | (1) |
|
|
277 | (2) |
|
|
277 | (1) |
|
New applications and new technologies |
|
|
277 | (2) |
|
|
279 | (1) |
Bibliography |
|
280 | (17) |
Index |
|
297 | |